These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15948250)

  • 1. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats.
    Zhao DC; Lei JX; Chen R; Yu WH; Zhang XM; Li SN; Xiang P
    World J Gastroenterol; 2005 Jun; 11(22):3431-40. PubMed ID: 15948250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
    Motawi TM; Atta HM; Sadik NA; Azzam M
    Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
    World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
    Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
    Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.
    Shao CH; Chen SL; Dong TF; Chai H; Yu Y; Deng L; Wang Y; Cheng F
    J Surg Res; 2014 Jan; 186(1):408-16. PubMed ID: 24071025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
    Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
    Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
    Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
    BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Efficiency of Different Routes of Bone Marrow-Derived Mesenchymal Stem Cell Injection in Rat Liver Fibrosis Model.
    Idriss NK; Sayyed HG; Osama A; Sabry D
    Cell Physiol Biochem; 2018; 48(5):2161-2171. PubMed ID: 30114694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte-like Versus Mesenchymal Stem Cells in CCl4-induced Liver Fibrosis.
    Ewida SF; Abdou AG; El-Rasol Elhosary AA; El-Ghane Metawe SA
    Appl Immunohistochem Mol Morphol; 2017; 25(10):736-745. PubMed ID: 27153445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of bone marrow-derived mesenchymal stem cells and imatinib in a rat model of liver fibrosis.
    Mazhari S; Gitiara A; Baghaei K; Hatami B; Rad RE; Asadirad A; Joharchi K; Tokhanbigli S; Hashemi SM; Łos MJ; Aghdaei HA; Zali MR; Ghavami S
    Eur J Pharmacol; 2020 Sep; 882():173263. PubMed ID: 32535098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.
    Abdel Aziz MT; Atta HM; Mahfouz S; Fouad HH; Roshdy NK; Ahmed HH; Rashed LA; Sabry D; Hassouna AA; Hasan NM
    Clin Biochem; 2007 Aug; 40(12):893-9. PubMed ID: 17543295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice.
    Fang B; Shi M; Liao L; Yang S; Liu Y; Zhao RC
    Transplantation; 2004 Jul; 78(1):83-8. PubMed ID: 15257043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver.
    Slautin V; Konyshev K; Gavrilov I; Beresneva O; Maklakova I; Grebnev D
    Curr Stem Cell Res Ther; 2024; 19(11):1484-1496. PubMed ID: 38204245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the Regenerative and Therapeutic Impacts of Bone Marrow Mesenchymal Stem Cells and Adipose Mesenchymal Stem Cells Pre-Treated with Melatonin on Liver Fibrosis.
    Elzainy A; El Sadik A; Altowayan WM
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of hematopoietic stem cells into hepatocytes in liver fibrosis in rats.
    Zhan Y; Wang Y; Wei L; Chen H; Cong X; Fei R; Gao Y; Liu F
    Transplant Proc; 2006 Nov; 38(9):3082-5. PubMed ID: 17112904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4.
    Mortezaee K; Khanlarkhani N; Sabbaghziarani F; Nekoonam S; Majidpoor J; Hosseini A; Pasbakhsh P; Kashani IR; Zendedel A
    Cell Tissue Res; 2017 Aug; 369(2):303-312. PubMed ID: 28413861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow derived-mesenchymal stem cells downregulate IL17A dependent IL6/STAT3 signaling pathway in CCl4-induced rat liver fibrosis.
    Farouk S; Sabet S; Abu Zahra FA; El-Ghor AA
    PLoS One; 2018; 13(10):e0206130. PubMed ID: 30346985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cord blood-derived mesenchymal stem cells with hepatogenic differentiation potential ameliorate chronic liver affection in experimental models.
    Kamel MM; Baz HGE; Demerdash Z; Hassan S; Salah F; Mansour WA; Hammam O; Atta S; Bayoumi A; Hassan M; Mahmoud S
    Adv Clin Exp Med; 2018 Oct; 27(10):1329-1339. PubMed ID: 30048056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice.
    An SY; Jang YJ; Lim HJ; Han J; Lee J; Lee G; Park JY; Park SY; Kim JH; Do BR; Han C; Park HK; Kim OH; Song MJ; Kim SJ; Kim JH
    Gastroenterology; 2017 Apr; 152(5):1174-1186. PubMed ID: 27956229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
    Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
    Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.